None listed
Conditions
Interventions
Intervention1: 5 product oil, 1 product gel: The 40 micro liter(After dilution for respective products as per EC Approved protocol)of each products will be loaded in IQ chambers and same will be paste
Sponsors
Dabur India Limited
Eligibility
Inclusion criteria
Inclusion criteria: • Subjects in age group 18 - 55 years • Healthy male & female subjects • Subjects with Fitzpatrick skin type III to V. • Subjects willing to give a written informed consent. • Subjects willing to maintain the patch test in position for 24 hours • Subject having not participated in a similar investigation in the past two weeks. • Subjects willing to come for regular follow up visits. • Subjects ready to follow instructions during the study period.
Exclusion criteria
Exclusion criteria: • Infection, allergy on the tested area • Skin allergy antecedents or atopic subjects • Hyper sensitivity to any component of the tested products • Athletes and subjects with history of excessive sweating • Cutaneous disease which may influence the study result • Chronic illness which may influence the cutaneous state. • Subjects on oral corticosteroid • Subjects participating in any other cosmetic or therapeutic study. • Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The objective of this study is to evaluate the dermatological safety of the investigational products on healthy human subjectsTimepoint: 0hr,24hr and 7days post patch removal | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Mukesh Ramnane
MS Clinical Research Pvt.Ltd.
Outcome results
None listed